ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Consumer Products

ZBiotics raises funds for hangover probiotic

by Ryan Cross
March 21, 2020 | APPEARED IN VOLUME 98, ISSUE 11

 

San Francisco–based ZBiotics has raised $2.3 million in seed funding from the venture capital firm Oyster Ventures. ZBiotics has engineered Bacillus subtilis to make acetaldehyde dehydrogenase, an enzyme that breaks down acetaldehyde, which some studies have linked to the hangover headache. The product is sold online. ZBiotics says the funds will help it scale up the hangover treatment and develop new engineered probiotics.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment